Pharming Group to participate in June investor conferences
June 03 2024 - 2:00AM
Leiden, the Netherlands, June 3,
2024: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management
will participate in the following investor conferences in the month
of June:
-
Jefferies Healthcare Conference, New York, USA, June 5-6,
2024Sijmen de Vries, Chief Executive Officer, will present
on Wednesday, June 5 at 10:30EDT/16:30CEST. A live webcast and
replay of the presentation will be available in the “Upcoming
Events” and “News” sections of Pharming’s website.
-
Oppenheimer Novel Targets in Immunology Summit, New York,
USA, June 24, 2024Anurag Relan, Chief Medical Officer,
will participate in the panel “Taking the Inflammation out of
I&I - Novel Approaches for Inflammatory Disorders” on Monday,
June 24 at 13:30EDT/19:30CEST.
-
Oppenheimer 2024 Montauk Life Sciences Summit, Montauk, NY,
USA, June 26-28, 2024
For more information about these conferences, or
to schedule a one-to-one meeting with Pharming’s management team,
please contact Pharming’s Investor Relations team at
investor@pharming.com or your Jefferies or Oppenheimer
representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules and biologics.
Pharming is headquartered in Leiden, the Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, the NetherlandsMichael
Levitan, VP Investor Relations & Corporate CommunicationsT: +1
(908) 705 1696E: investor@pharming.com
FTI Consulting, London, United KingdomVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam,
the NetherlandsLeon MelensT: +31 6 53 81 64 27E:
pharming@lifespring.nl
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Aug 2023 to Aug 2024